Nova Bay Pharmaceuticals, Inc. NBY
We take great care to ensure that the data presented and summarized in this overview for NovaBay Pharmaceuticals, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NBY
View allLatest Institutional Activity in NBY
Top Purchases
Top Sells
About NBY
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Insider Transactions at NBY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 08
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300
+0.03%
|
$0
$0.46 P/Share
|
|
Apr 04
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,538
+0.44%
|
$0
$0.52 P/Share
|
|
Apr 03
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,976
+2.21%
|
$0
$0.56 P/Share
|
|
Apr 02
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
917
+0.09%
|
$0
$0.58 P/Share
|
|
Apr 01
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
19,915
+1.97%
|
$0
$0.58 P/Share
|
|
Mar 31
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,654
+2.18%
|
$0
$0.59 P/Share
|
|
Mar 28
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
49,400
+4.94%
|
$0
$0.61 P/Share
|
|
Mar 27
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
19,104
+1.04%
|
$0
$0.62 P/Share
|
|
Mar 26
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,292
+1.49%
|
$0
$0.61 P/Share
|
|
Mar 25
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,635
+2.54%
|
$0
$0.61 P/Share
|
|
Mar 24
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100
+0.01%
|
$0
$0.6 P/Share
|
|
Mar 21
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,372
+0.75%
|
$0
$0.6 P/Share
|
|
Mar 20
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,320
+0.63%
|
$0
$0.61 P/Share
|
|
Mar 19
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,500
+0.18%
|
$0
$0.6 P/Share
|
|
Mar 18
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
24,000
+1.43%
|
$0
$0.63 P/Share
|
|
Mar 14
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,511
+3.06%
|
$0
$0.63 P/Share
|
|
Mar 13
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
34
+0.0%
|
$0
$0.64 P/Share
|
|
Mar 12
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,837
+1.49%
|
$0
$0.62 P/Share
|
|
Mar 11
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,148
+0.28%
|
$0
$0.58 P/Share
|
|
Mar 10
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,645
+1.87%
|
$0
$0.58 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 502K shares |
|---|